Tectonic Therapeutic reported $283.77M in Equity Capital and Reserves for its fiscal quarter ending in June of 2025.




Equity Capital And Reserves Change Date
Adcock Ingram Holdings ZAR 5.54B 131.19M Dec/2024
Alnylam Pharmaceuticals USD 250.59M 135.16M Jun/2025
Celltrion KRW 17.14T 298.25B Mar/2025
Cspc Pharmaceutical CNY 32.26B 2.59B Dec/2024
Dianthus Therapeutics USD 303.08M 49.4M Jun/2025
Divis Laboratories Ltd 149.69B 12.52B Mar/2025
Gilead Sciences USD 19.67B 596M Jun/2025
Ionis Pharmaceuticals USD 631.72M 156M Jun/2025
Kangmei Pharma CNY 7.73B 546.26M Jun/2025
Knight Therapeutics CAD 773.91M 11.11M Sep/2024
Laboratorios Farma EUR 574.72M 6.82M Jun/2025
MacroGenics USD 46.62M 69.44M Jun/2025
Malin Corporation EUR 193.2M 75M Dec/2024
Medical Developments International AUD 55.33M 9.6M Dec/2024
Neuren Pharmaceuticals AUD 363.9M 144.75M Dec/2024
Organigram Holdings CAD 385.5M 61.85M Jun/2025
Pfizer USD 88.7B 1.64B Jun/2025
Pharma Mar EUR 201.53M 4.06M Jun/2025
Qiagen NV USD 3.51B 97.61M Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
Sanofi EUR 70.28B 3.8B Jun/2025
Sarepta Therapeutics USD 1.36B 214.66M Jun/2025
Sartorius EUR 2.66B 51.3M Jun/2025
Sino Biopharmaceutical CNY 31.96B 884.2M Dec/2024
Takeda JPY 6.87T 69.82B Jun/2025
Tilray USD 3.47B 5.16M Nov/2024
Zz Pientze Pharmaceu 14.65B 617.48M Jun/2025